Betnesol-N 0.1% w/v, 3500 IU/ml Eye, Ear and Nasal Drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

betnesol-n 0.1% w/v, 3500 iu/ml eye, ear and nasal drops, solution

rph pharmaceuticals ab - neomycin sulfate; betamethasone sodium phosphate - ear/eye/nasal drops, solution - 0.1% w/v 3500  international unit(s)/millilitre - corticosteroids and antiinfectives in combination; betamethasone and antiinfectives

LAEOVATE N DROPS Ear/Eye Drops, Solution Kenya - English - Pharmacy and Poisons Board

laeovate n drops ear/eye drops, solution

laboratory & allied ltd p.o box 42875 gpo 00100 nairobi, kenya - betamethasone sodium phosphate neomycin sulphate… - ear/eye drops, solution - betamethasone sodium phosphate bp 0.1 % w/v … - otological anti-infectives

BETNESOL-N 0.01% W/W, 3500 IU/ML EYE OINTMENT 0.1/0.5%w/ %v/v Eye Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

betnesol-n 0.01% w/w, 3500 iu/ml eye ointment 0.1/0.5%w/ %v/v eye ointment

ucb pharma limited - betamethasone sodium phosphate neomycin sulfate - eye ointment - 0.1/0.5%w/ %v/v

Betnesol N New Zealand - English - Medsafe (Medicines Safety Authority)

betnesol n

glaxosmithkline nz limited - betamethasone sodium phosphate 0.1%{relative} (0.105% including 10% manufacturers overage.); neomycin sulfate 0.5%{relative} (0.55% incl. 10% overage. equiv. to 0.385%w/v neomycin base.);   - ear/eye drops - active: betamethasone sodium phosphate 0.1%{relative} (0.105% including 10% manufacturers overage.) neomycin sulfate 0.5%{relative} (0.55% incl. 10% overage. equiv. to 0.385%w/v neomycin base.)   excipient: benzalkonium chloride dibasic sodium phosphate disodium edetate dihydrate macrogol 300 monobasic sodium phosphate dihydrate phosphoric acid purified water sodium formate sodium hydroxide sodium sulfate

Ultrazon N Eye/Ear Drops New Zealand - English - Medsafe (Medicines Safety Authority)

ultrazon n eye/ear drops

douglas pharmaceuticals limited - betamethasone sodium phosphate 0.1%{relative}; neomycin sulfate 0.5%{relative} - ear/eye drops - 0.1%/0.5% - active: betamethasone sodium phosphate 0.1%{relative} neomycin sulfate 0.5%{relative}

BETACIN EYE/EAR DROPS Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

betacin eye/ear drops

duopharma (m) sdn. bhd. - betamethasone sodium phosphate; neomycin sulphate -

BETACIN EYEEAR DROPS Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

betacin eyeear drops

duopharma (m) sdn. bhd. - betamethasone sodium phosphate; neomycin sulphate -

PREDNISOLONE SODIUM PHOSPHATE solution United States - English - NLM (National Library of Medicine)

prednisolone sodium phosphate solution

proficient rx lp - prednisolone sodium phosphate (unii: iv021nxa9j) (prednisolone - unii:9phq9y1olm) - prednisolone 15 mg in 5 ml - prednisolone sodium phosphate oral solution (15 mg prednisolone per 5 ml) is indicated in the following conditions: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. pemphigus; bullous dermatitis herpetiformis; severe erythema multiforme (stevens-johnson syndrome); exfoliative erythroderma; mycosis fungoides. to induce diuresis or remission of proteinuria in nephrotic syndrome in adults with lupus erythematosus and in adults and pediatric populations, with idiopathic nephrotic syndrome, without uremia. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance); congenital ad

PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION- prednisolone sodium phosphate solution United States - English - NLM (National Library of Medicine)

prednisolone sodium phosphate oral solution- prednisolone sodium phosphate solution

mission pharmacal company - prednisolone sodium phosphate (unii: iv021nxa9j) (prednisolone - unii:9phq9y1olm) - prednisolone 25 mg in 5 ml - prednisolone sodium phosphate oral solution (25 mg prednisolone per 5 ml) is indicated in the following conditions: 1. allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. 2. dermatologic diseases pemphigus; bullous dermatitis herpetiformis; severe erythema multiforme (stevens-johnson syndrome); exfoliative erythroderma; mycosis fungoides. 3. edematous states to induce diuresis or remission of proteinuria in nephrotic syndrome in adults with lupus erythematosus and in adults and pediatric populations, with idiopathic nephritic syndrome, without uremia. 4. endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; i

DOM-GENTAMICIN-BETAMETHASONE LIQUID Canada - English - Health Canada

dom-gentamicin-betamethasone liquid

dominion pharmacal - betamethasone (betamethasone sodium phosphate); gentamicin (gentamicin sulfate) - liquid - 1mg; 3mg - betamethasone (betamethasone sodium phosphate) 1mg; gentamicin (gentamicin sulfate) 3mg - antibacterials